I’d like to ask this community about the wisdom of adding Casodex to standard ADT.
Background: Dx Feb 2018, PSA 168; multiple mets to bones. Firmagon monthly Feb - Nov switched to 3 monthly Dipherelin in Nov. 6 rounds of Docetaxel Apr - Jul. PSA nadir 0.4 in Aug. rose slightly to 0.64 by Mar 2019. On Atorvastatin, Celebrex, Metformin and a number of supplements: Ca/Mg/D3, MCP, Melatonin, Vit E (Tocotrienols), Broccomax, 5-Loxin.
My MO didn’t suggest any additional treatment at this time, so I sought a second opinion from another MO. Basically he agreed the current treatment was fine but suggested that adding Bicalutamide could possibly reduce my PSA further.
My question is: is this a good idea? Is there any problem with adding Bicalutamide? I’ve read that it was a predecessor to Enzalutamide but not as effective as E. Would taking it now mean that Enzalutamide would be out as an option later? Would taking it reduce the effectiveness of Abiraterone?
Any wise thoughts from the experts in this community would be most appreciated. Thanks.